Developer docs
API playgroundTry for free, no card

Search company profiles

Europa Biosite

Full company profile

uuid00098fm

Namestring
Europa Biosite
Legal namestring
Nordic BioSite Holding AB
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Europa Biosite (legal entity Nordic BioSite Holding AB, company number 559210-7428) is a privately held life science distributor headquartered in Täby, Sweden, operating in 17 countries across Europe and North America through seven wholly-owned regional subsidiaries: Amsbio (USA), Biomol (Germany), Cambridge Bioscience (UK and Ireland), LubioScience (Switzerland), Nordic Biosite (Nordics and Baltics), Sanbio (Benelux) and Szabo-Scandic (Austria), with UK-based Stratech Scientific added in February 2026. The company's core offering is the distribution of more than 10 million research-use-only life science products — reagents, kits and advanced technologies — to academic research institutions, biotechnology companies and pharmaceutical R&D organizations, with all products explicitly labeled for research use only and not for diagnostic or therapeutic use.

The underlying technology is principally the distribution platform itself: a pan-European commercial infrastructure that delivers locally-tailored sales, customer support and regulatory-compliant (GDPR, RUO) handling in each market while aggregating supplier relationships centrally. Recent additions to the portfolio include Ntensify mano and Ntensify micro RNA production technologies and forthcoming Ncapsulate LNP formulation kits from Quantoom Biosciences (partnership announced 17 March 2026), extending the offering into mRNA and lipid nanoparticle workflows.

Revenue is generated through B2B distribution across the subsidiary network under channel-partner commercial arrangements with global life science suppliers; pricing is not publicly disclosed. The company was acquired by EQT Healthcare Growth in July 2025 from Adelis Equity, appointed Claudia Berrón as CEO effective 1 April 2026, and is actively pursuing further acquisitions and supplier partnerships to broaden its technology coverage and geographic footprint.

Short descriptiontext

Europa Biosite is a privately held, pan-European life science distributor operating in 17 countries across Europe and North America through seven regional subsidiaries, supplying more than 10 million research-use-only reagents and technologies to academic, biotech and pharmaceutical R&D customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersTäby, Sweden
HQ citystring
Täby
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science distribution, research reagent supply, biotechnology product distribution, pan-European laboratory supplies, RUO reagent distribution
Industry2 codes
1Bioprocess Consumables & Reagents (resins, membranes, media components, buffers)
CodeHLAAAJAIPrimaryYes
2mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA)
CodeHLAGAGACPrimaryNo
NAICS code1 code
  • Analytical Laboratory Instrument Manufacturing334516
SIC code2 codes
  • Laboratory Apparatus & Furniture3821
  • Laboratory Analytical Instruments3826
Product category
Life Science Distribution
No data
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Life Science Product Distribution
TypeSubscription Recurring
Description

Europa Biosite generates revenue through distributing life science reagents and products for healthcare R&D. The company supplies over ten million research-use-only products across 17 countries in Europe and North America. Revenue is derived from sales through its pan-European distribution network to academic, biotech, and pharmaceutical laboratories.

europabiosite.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Europa Biosite is a pan-European life science product distributor that sources research-use-only reagents, biotechnology tools, and advanced technologies from global manufacturers and resells them to academic, biotechnology, and pharmaceutical customers across 17 countries in Europe and North America. The company operates through locally-based regional subsidiaries (Amsbio, Biomol, Cambridge Bioscience, LubioScience, Nordic Biosite, Sanbio, Szabo-Scandic), distributing over ten million products including emerging RNA production technologies such as Ntensify® mano, Ntensify® micro, and forthcoming Ncapsulate® LNP formulation kits.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Geographic partnership expansion results in double digit growth
+2 more records
Product overview1 text field

Europa Biosite is a pan-European life science product distributor that operates as a platform of regional subsidiaries, rather than a single unified product. The company distributes over ten million research-use-only products across 17 countries through its network of regional subsidiaries (Amsbio in USA, Biomol in Germany, Cambridge Bioscience in UK/Ireland, LubioScience in Switzerland, Nordic Biosite in Nordics/Baltics, Sanbio in Benelux, Szabo-Scandic in Austria). Recently, the company has expanded into RNA research technologies through a distribution partnership with Quantoom Biosciences, adding Ntensify® mano, Ntensify® micro, and upcoming Ncapsulate® LNP formulation kits to its portfolio. The company also acquired UK distributor Stratech Scientific in February 2026. Products are explicitly labeled for research use only and are not intended for diagnostic or therapeutic use.

Product and service4 records
1Ntensify® mano RNA production technology
CategoryDistributed life science research technology
Description

Rapid and qualitative RNA production technology for research settings, manufactured by Quantoom Biosciences and distributed by Europa Biosite across Europe for life science researchers.

2Ntensify® micro RNA production technology
CategoryDistributed life science research technology
Description

Rapid and qualitative RNA production technology for research settings, manufactured by Quantoom Biosciences and distributed by Europa Biosite across Europe for life science researchers.

3Ncapsulate® LNP Formulation Kits
CategoryDistributed life science research technology
Description

LNP (lipid nanoparticle) formulation kits for RNA research, to be distributed by Europa Biosite across Europe as they become available under the partnership with Quantoom Biosciences.

4Pan-European research reagent distribution
CategoryLife science distribution services
Description

Distribution of over 10 million research-use-only life science reagents and products to academic, biotechnology, and pharmaceutical laboratories across 17 countries in Europe and North America via locally-based regional subsidiaries.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-03-17
Description

Strategic distribution partnership where Europa Biosite distributes Quantoom's Ntensify® mano and Ntensify® micro RNA production technologies across Europe. The agreement expands Europa Biosite's portfolio in the rapidly growing RNA research field and is expected to extend to include Ncapsulate® LNP formulation kits as they become available. The partnership aims to make high-quality RNA production and formulation tools more accessible to researchers, accelerating development of next-generation RNA applications and therapeutics.

Strategic tierCoreTypeOthersAnnounced on2026-02-27
Description

Europa Biosite acquired Stratech Scientific through its UK subsidiary Cambridge Bioscience. Stratech Scientific is a well-respected, long-established UK life science distributor known for high quality research reagents and strong supplier partnerships. The acquisition significantly expands Europa Biosite's UK product offering, broadens reach across academic and industrial research communities, and strengthens Cambridge Bioscience's position as a leading partner for UK life science researchers. Integrating Stratech Scientific with Cambridge Bioscience combines complementary portfolios, creating greater choice for UK researchers.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Avantor is the largest global life science and laboratory distribution platform following its VWR acquisition; it directly competes with Europa Biosite across European research reagent and lab supplies, and Avantor is also the former employer of Europa Biosite's incoming CEO.

TypeBroad incumbent
Description

Thermo Fisher is the world's largest life science tools and reagents company, competing with Europa Biosite as a one-stop supplier of research reagents, lab consumables, and analytical instruments to academic and biotech customers across Europe and the US.

TypeBroad incumbent
Description

Bio-Rad supplies life science research reagents, clinical diagnostics, and laboratory instruments through a distributor-led model in Europe, overlapping meaningfully with Europa Biosite's research-use reagent and instrument portfolio.

TypeBroad incumbent
Description

Cytiva is a major supplier of bioprocess consumables, resins, and filtration products, and its products flow through distributors like Europa Biosite's Biomol and Cambridge Bioscience subsidiaries, making it both a partner and competitive reference point in bioprocess distribution.

TypeBroad incumbent
Description

Merck's Life Science division, including the Sigma-Aldrich portfolio, is a direct competitor in the distribution of research reagents, bioprocess consumables, and laboratory chemicals to European academic and pharmaceutical customers.

TypeEmerging player
Description

Bio-Techne develops and distributes high-margin research reagents (proteins, antibodies, assays) and relies on European distribution partners - structurally adjacent to Europa Biosite's premium reagent portfolio and a relevant comparable on pricing power.

TypeBroad incumbent
Description

Revvity operates life sciences reagents, analytical instruments, and software across academic and pharma research customers, overlapping with Europa Biosite's instrument and reagent distribution business in Europe and the US.

TypeEmerging player
Description

Stemcell Technologies distributes cell culture and research reagents via a network of regional distributors across Europe; it shares Europa Biosite's model of serving academic and biotech researchers with specialized life science products through local sales representation.

TypeRegional player
Description

Sarstedt is a European-headquartered manufacturer and direct distributor of laboratory consumables and sample collection products, overlapping with Europa Biosite's lab consumables and reagent categories across the DACH region.

TypeEmerging player
Description

Tecan manufactures liquid handling and analytical instruments distributed to academic and pharma research labs; it is both a potential partner brand in Europa Biosite's portfolio and a comparable on European life science distribution economics.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries8 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Europa Biosite

Life Science Distributioneuropabiosite.com

Europa Biosite is a privately held, pan-European life science distributor operating in 17 countries across Europe and North America through seven regional subsidiaries, supplying more than 10 million research-use-only reagents and technologies to academic, biotech and pharmaceutical R&D customers.

What Europa Biosite does

Europa Biosite (legal entity Nordic BioSite Holding AB, company number 559210-7428) is a privately held life science distributor headquartered in Täby, Sweden, operating in 17 countries across Europe and North America through seven wholly-owned regional subsidiaries: Amsbio (USA), Biomol (Germany), Cambridge Bioscience (UK and Ireland), LubioScience (Switzerland), Nordic Biosite (Nordics and Baltics), Sanbio (Benelux) and Szabo-Scandic (Austria), with UK-based Stratech Scientific added in February 2026. The company's core offering is the distribution of more than 10 million research-use-only life science products — reagents, kits and advanced technologies — to academic research institutions, biotechnology companies and pharmaceutical R&D organizations, with all products explicitly labeled for research use only and not for diagnostic or therapeutic use.

The underlying technology is principally the distribution platform itself: a pan-European commercial infrastructure that delivers locally-tailored sales, customer support and regulatory-compliant (GDPR, RUO) handling in each market while aggregating supplier relationships centrally. Recent additions to the portfolio include Ntensify mano and Ntensify micro RNA production technologies and forthcoming Ncapsulate LNP formulation kits from Quantoom Biosciences (partnership announced 17 March 2026), extending the offering into mRNA and lipid nanoparticle workflows.

Revenue is generated through B2B distribution across the subsidiary network under channel-partner commercial arrangements with global life science suppliers; pricing is not publicly disclosed. The company was acquired by EQT Healthcare Growth in July 2025 from Adelis Equity, appointed Claudia Berrón as CEO effective 1 April 2026, and is actively pursuing further acquisitions and supplier partnerships to broaden its technology coverage and geographic footprint.

Europa Biosite firmographics

Firmographics
Name
Europa Biosite
Legal name
Nordic BioSite Holding AB
Website
https://www.europabiosite.com/
Company type
Private
Operating status
Operating
Headcount range
101–250 employees
Short description
Europa Biosite is a privately held, pan-European life science distributor operating in 17 countries across Europe and North America through seven regional subsidiaries, supplying more than 10 million research-use-only reagents and technologies to academic, biotech and pharmaceutical R&D customers.
Ownership category
akta.pro rank

Europa Biosite industry classification

Industry
Product category
Life Science Distribution
NAICS
Analytical Laboratory Instrument Manufacturing (334516)
SIC
Laboratory Apparatus & Furniture (3821), Laboratory Analytical Instruments (3826)
akta.pro primary industry
Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI)
akta.pro secondary industry
mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

Keywords

  • Life science distribution
  • Research reagent supply
  • Biotechnology product distribution
  • Pan-European laboratory supplies
  • RUO reagent distribution

Where Europa Biosite is headquartered

Location

Headquarters

HQ city
Täby
HQ country
Sweden
HQ region
Europe

Offices8 records

Markets served

Europa Biosite business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Life Science Product Distribution: Europa Biosite generates revenue through distributing life science reagents and products for healthcare R&D. The company supplies over ten million research-use-only products across 17 countries in Europe and North America. Revenue is derived from sales through its pan-European distribution network to academic, biotech, and pharmaceutical laboratories.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Europa Biosite product offering

Product offering

Core offering

Europa Biosite is a pan-European life science product distributor that sources research-use-only reagents, biotechnology tools, and advanced technologies from global manufacturers and resells them to academic, biotechnology, and pharmaceutical customers across 17 countries in Europe and North America. The company operates through locally-based regional subsidiaries (Amsbio, Biomol, Cambridge Bioscience, LubioScience, Nordic Biosite, Sanbio, Szabo-Scandic), distributing over ten million products including emerging RNA production technologies such as Ntensify® mano, Ntensify® micro, and forthcoming Ncapsulate® LNP formulation kits.

Product overview

Europa Biosite is a pan-European life science product distributor that operates as a platform of regional subsidiaries, rather than a single unified product. The company distributes over ten million research-use-only products across 17 countries through its network of regional subsidiaries (Amsbio in USA, Biomol in Germany, Cambridge Bioscience in UK/Ireland, LubioScience in Switzerland, Nordic Biosite in Nordics/Baltics, Sanbio in Benelux, Szabo-Scandic in Austria). Recently, the company has expanded into RNA research technologies through a distribution partnership with Quantoom Biosciences, adding Ntensify® mano, Ntensify® micro, and upcoming Ncapsulate® LNP formulation kits to its portfolio. The company also acquired UK distributor Stratech Scientific in February 2026. Products are explicitly labeled for research use only and are not intended for diagnostic or therapeutic use.

Differentiator

Problem solved

Functional benefit

Products and services

  • Ntensify® mano RNA production technology Rapid and qualitative RNA production technology for research settings, manufactured by Quantoom Biosciences and distributed by Europa Biosite across Europe for life science researchers.
  • Ntensify® micro RNA production technology Rapid and qualitative RNA production technology for research settings, manufactured by Quantoom Biosciences and distributed by Europa Biosite across Europe for life science researchers.
  • Ncapsulate® LNP Formulation Kits LNP (lipid nanoparticle) formulation kits for RNA research, to be distributed by Europa Biosite across Europe as they become available under the partnership with Quantoom Biosciences.
  • Pan-European research reagent distribution Distribution of over 10 million research-use-only life science reagents and products to academic, biotechnology, and pharmaceutical laboratories across 17 countries in Europe and North America via locally-based regional subsidiaries.

Quantifiable outcome

  • Geographic partnership expansion results in double digit growth
  • +2 more outcomes

Companies that use Europa Biosite

Customer profile

Segments3 records

Ideal customer profiles4 records

Europa Biosite technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Europa Biosite partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Quantoom BiosciencescoreChannel Partner/ Reseller/ Distributor · 17 March 2026Strategic distribution partnership where Europa Biosite distributes Quantoom's Ntensify® mano and Ntensify® micro RNA production technologies across Europe. The agreement expands Europa Biosite's portfolio in the rapidly growing RNA research field and is expected to extend to include Ncapsulate® LNP formulation kits as they become available. The partnership aims to make high-quality RNA production and formulation tools more accessible to researchers, accelerating development of next-generation RNA applications and therapeutics.
  • Stratech ScientificcoreOthers · 27 February 2026Europa Biosite acquired Stratech Scientific through its UK subsidiary Cambridge Bioscience. Stratech Scientific is a well-respected, long-established UK life science distributor known for high quality research reagents and strong supplier partnerships. The acquisition significantly expands Europa Biosite's UK product offering, broadens reach across academic and industrial research communities, and strengthens Cambridge Bioscience's position as a leading partner for UK life science researchers. Integrating Stratech Scientific with Cambridge Bioscience combines complementary portfolios, creating greater choice for UK researchers.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Europa Biosite competitors and assessment

Company assessment

Broad incumbents

  • Avantor: Avantor is the largest global life science and laboratory distribution platform following its VWR acquisition; it directly competes with Europa Biosite across European research reagent and lab supplies, and Avantor is also the former employer of Europa Biosite's incoming CEO.
  • Thermo Fisher Scientific: Thermo Fisher is the world's largest life science tools and reagents company, competing with Europa Biosite as a one-stop supplier of research reagents, lab consumables, and analytical instruments to academic and biotech customers across Europe and the US.
  • Bio-Rad Laboratories: Bio-Rad supplies life science research reagents, clinical diagnostics, and laboratory instruments through a distributor-led model in Europe, overlapping meaningfully with Europa Biosite's research-use reagent and instrument portfolio.
  • Cytiva (Danaher): Cytiva is a major supplier of bioprocess consumables, resins, and filtration products, and its products flow through distributors like Europa Biosite's Biomol and Cambridge Bioscience subsidiaries, making it both a partner and competitive reference point in bioprocess distribution.
  • Merck KGaA (Life Science / Sigma-Aldrich): Merck's Life Science division, including the Sigma-Aldrich portfolio, is a direct competitor in the distribution of research reagents, bioprocess consumables, and laboratory chemicals to European academic and pharmaceutical customers.
  • Revvity (formerly PerkinElmer Life Sciences): Revvity operates life sciences reagents, analytical instruments, and software across academic and pharma research customers, overlapping with Europa Biosite's instrument and reagent distribution business in Europe and the US.

Emerging players

  • Bio-Techne: Bio-Techne develops and distributes high-margin research reagents (proteins, antibodies, assays) and relies on European distribution partners - structurally adjacent to Europa Biosite's premium reagent portfolio and a relevant comparable on pricing power.
  • Stemcell Technologies: Stemcell Technologies distributes cell culture and research reagents via a network of regional distributors across Europe; it shares Europa Biosite's model of serving academic and biotech researchers with specialized life science products through local sales representation.
  • Tecan: Tecan manufactures liquid handling and analytical instruments distributed to academic and pharma research labs; it is both a potential partner brand in Europa Biosite's portfolio and a comparable on European life science distribution economics.

Regional players

  • Sarstedt: Sarstedt is a European-headquartered manufacturer and direct distributor of laboratory consumables and sample collection products, overlapping with Europa Biosite's lab consumables and reagent categories across the DACH region.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Europa Biosite compliance and trust

Trust signal

Compliance2 records

Europa Biosite financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Europa Biosite leadership team

Management profile

Number of profiles

Profiles4 records

Europa Biosite subsidiaries and ownership

Company hierarchy

Subsidiaries8 records

Europa Biosite funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Europa Biosite M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Europa Biosite

What does Europa Biosite do?

Europa Biosite is a pan-European life science product distributor that sources research-use-only reagents, biotechnology tools, and advanced technologies from global manufacturers and resells them to academic, biotechnology, and pharmaceutical customers across 17 countries in Europe and North America. The company operates through locally-based regional subsidiaries (Amsbio, Biomol, Cambridge Bioscience, LubioScience, Nordic Biosite, Sanbio, Szabo-Scandic), distributing over ten million products including emerging RNA production technologies such as Ntensify® mano, Ntensify® micro, and forthcoming Ncapsulate® LNP formulation kits.

Is Europa Biosite a public or private company?

Europa Biosite is a private company. It is classified as private equity controlled and is currently operating.

When was Europa Biosite founded?

Europa Biosite was founded in -1. It employs 101 to 250 people.

Where is Europa Biosite based?

Europa Biosite is headquartered in Täby, Sweden, in the Europe region.

How does Europa Biosite make money?

One revenue line is on record: life Science Product Distribution.

Who are Europa Biosite's main competitors?

Broad incumbents on record are Avantor, Thermo Fisher Scientific, Bio-Rad Laboratories, Cytiva (Danaher), Merck KGaA (Life Science / Sigma-Aldrich) and Revvity (formerly PerkinElmer Life Sciences). Emerging players are Bio-Techne, Stemcell Technologies and Tecan. Sarstedt is listed as a regional player.

Does Europa Biosite have an API?

No public API is recorded for Europa Biosite.

What industry is Europa Biosite in?

Europa Biosite's product category is Life Science Distribution. Its primary akta.pro industry code is HLAAAJAI, Bioprocess Consumables & Reagents (resins, membranes, media components, buffers), with a secondary code of HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 334516 and its SIC code is 3821.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
startupticker.chFour Swiss medtechs mark commercial, regulatory and clinical milestonesFour Swiss medtech companies have announced significant commercial, regulatory and clinical milestones: arcoris bio signed a distribution partnership with Europa Biosite to expand its MUSE biomarker-detection kits across Europe and North America, while Hi-D Imaging secured expanded FDA 510(k) clearance for its AI-driven TAVR planning software to include vascular-access analysis. ABILITY Neurotech completed its first-in-human brain-computer interface procedure at TUM University Hospital in Munich, and Alivion published validation data for its handheld breath-analysis device, all representing key advancement stages for the respective technologies.News-Medicalarcoris bio and Europa Biosite partner to bring immunoMUSE® kits to Europe and North American marketarcoris bio AG, a Swiss life science research tools and in vitro diagnostics company, announced a distribution partnership with Europa Biosite to distribute its newly launched immunoMUSE® kits across European markets and North America. The immunoMUSE® kits enable researchers to create custom multiplex immunofluorescence panels using their preferred antibodies, leveraging MUSE® technology for high-sensitivity biomarker detection. Matyas Vegh, CEO of arcoris bio, and Sebastian Buchert, Group Product Director at Europa Biosite, commented on the strategic fit of the partnership.BiotechniquesEuropa Biosite introduces rapid RNA production technologiesEuropa Biosite, a pan-European life science distributor headquartered in Täby, Sweden, announced a strategic distribution partnership with Quantoom Biosciences of Nivelles, Belgium, to distribute Quantoom's Ntensify® mano and Ntensify® micro RNA production technologies across Europe. The agreement expands Europa Biosite's portfolio in the rapidly growing RNA research field and is expected to extend to include Ncapsulate® LNP formulation kits as they become available. The companies aim to make high-quality RNA production and formulation tools more accessible to researchers, accelerating development of next-generation RNA applications and therapeutics.AInvestEuropa Biosite Expands Bio X Cell Partnership with Cambridge Bioscience in UK & IrelandEuropa Biosite partnered with Cambridge Bioscience to distribute Bio X Cell's functional monoclonal antibodies in the UK and Ireland. The collaboration aims to support biomedical studies and aligns with a projected life science tools market growth to $402.18 billion by 2032.Pulse 2.0EQT Healthcare Growth To Buy Europa BiositeEQT Healthcare Growth agreed to acquire a majority stake in Europa Biosite, a Stockholm-based distributor of research-use-only life science reagents. The company operates in 17 countries and supports over 60,000 researchers. EQT plans to help Europa Biosite expand biospecimen offerings, strengthen local presence, enter new regions, and invest in digital infrastructure.TradingViewEQT to acquire Europa Biosite, a distributor of life science productsEQT Healthcare Growth agreed to acquire a majority stake in Europa Biosite, a distributor of life science reagents, from Adelis Equity. The company operates in 17 countries and supports over 60,000 researchers. It plans to expand its own-brand biospecimens, continue acquisitions, and invest in digital infrastructure.AInvestEQT's Strategic Play in Life Sciences: Europa Biosite Acquisition Unlocks Growth PotentialEQT Healthcare Growth acquired a majority stake in Europa Biosite on July 3, 2025, to scale specialized life sciences distribution. The deal leverages EQT's $1.7 billion operating cash flow and prior M&A successes, targeting a $50 billion U.S. market. The acquisition aims to drive growth through digital integration, geographic expansion, and own-brand product lines.PR NewswireEQT to acquire Europa Biosite, a distributor of life science productsEQT Healthcare Growth agreed to acquire a majority stake in Europa Biosite, a distributor of life science reagents, from Adelis Equity. The company operates in 17 countries and supports over 60,000 researchers, offering access to over ten million scientific products. EQT will support growth through digital upgrades, expanded product access, and continued M&A.